OyaGen Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:OyaGen Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10912
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
OyaGen Inc (OyaGen) is a biotechnology company that discovers, develops and commercializes novel pharmaceutical therapies. The company offers viral infectivity factor Dimerization Antagonist, Vif Interaction with APOBEC3G, Vif dependent polyubiquitination of APOBEC3G and APOBEC3G activators. It utilizes RNA editing and DNA editing enzymes to develop pharmaceutical therapies. OyaGen provides therapeutics for the treatment of diseases caused by human immunodeficiency virus. The company’s RNA editing and DNA editing enzymes are endogenous cellular proteins which chemically alter RNA or DNA molecules and change the genetic code. OyaGen is headquartered in Henrietta, New York, the US.

OyaGen Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OyaGen Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
OyaGen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
OyaGen Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
OyaGen Raises USD0.3 Million in Venture Financing 10
OyaGen Raises US$0.1 Million In Venture Financing 11
Oyagen Raises US$2 Million In Venture Financing 12
OyaGen Inc – Key Competitors 13
OyaGen Inc – Key Employees 14
OyaGen Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
OyaGen Inc, Pharmaceuticals & Healthcare, Key Facts 2
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OyaGen Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OyaGen Inc, Deals By Therapy Area, 2012 to YTD 2018 8
OyaGen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
OyaGen Raises USD0.3 Million in Venture Financing 10
OyaGen Raises US$0.1 Million In Venture Financing 11
Oyagen Raises US$2 Million In Venture Financing 12
OyaGen Inc, Key Competitors 13
OyaGen Inc, Key Employees 14

List of Figures
OyaGen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OyaGen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OyaGen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[OyaGen Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tohoku Electric Power Company, Incorporated:企業の戦略・SWOT・財務分析
    Tohoku Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Tohoku Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • LifeAssays ABの企業概要及び財務/SWOT分析
    LifeAssays AB Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, LifeAssays AB annual and quarterly forecasts made by stock market experts. The report also enables direct compar …
  • Ford Motor Company:企業の戦略・SWOT・財務情報
    Ford Motor Company - Strategy, SWOT and Corporate Finance Report Summary Ford Motor Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Heiwa Real Estate Co., Ltd. (8803):企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Heiwa Real Estate Co., Ltd." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strict …
  • Jiangsu Holly Corporation (600128):企業の財務及び戦略的SWOT分析
    Summary Jiangsu Holly Corporation (Jiangsu) is a consumer product company that offers trading services. The company manufactures and markets apparel, fashion products, hardware, tools, gifts, crafts, home supplies, sports and entertainment, textile, fabric and toys. Its products include footwear, gl …
  • Sunac China Holdings Limited:企業の戦略・SWOT・財務分析
    SummarySunac China Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company …
  • UniCredit S.p.A:企業のM&A・事業提携・投資動向
    UniCredit S.p.A - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's UniCredit S.p.A Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Beaver Aerospace and Defense, Inc.(航空・防衛):企業概要、SWOT分析
    Summary Strategic Defence Intelligence's "Beaver Aerospace and Defense, Inc.: Aerospace and Defense - Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT …
  • Australian Gas Networks Ltd-エネルギー分野:企業M&A・提携分析
    Summary Australian Gas Networks Ltd (Australian Gas Networks) formerly Envestra Ltd, is an oil and gas company that distributes and transports natural gas. The company offers services such as managing the haulage of gas through each network, operation and maintenance of gas network, design an constr …
  • Aquarius Platinum Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Aquarius Platinum Limited Merge …
  • Anglo Pacific Group plc:企業のM&A・事業提携・投資動向
    Anglo Pacific Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Anglo Pacific Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • PNE Wind AG (PNE3):企業の財務・戦略的SWOT分析
    PNE Wind AG (PNE3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Collins Foods Ltd (CKF):企業の財務・戦略的SWOT分析
    Collins Foods Ltd (CKF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Ramco Industries Limited (RAMCOIND):企業の財務及び戦略的SWOT分析
    Summary Ramco Industries Limited (Ramco) is a cement product manufacturing company that offers construction material and other products. The company's products include fibre cement roofing sheets, roofing accessories, hilux calcium silicate boards, and fibre cement pressure pipes. Its accessories in …
  • Telerx Marketing Inc.:企業の戦略的SWOT分析
    Telerx Marketing Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Biovet AD (53B):企業財務及び戦略的SWOT分析
    Summary Biovet AD (Biovet), a subsidiary of Huvepharma AD is a chemical company that manufactures and markets bulk active substances, medicated and nutritional feed additives, enzymes, and pharmaceuticals for animal health. It offers products such as intermediates, enzymes, active ingredients and me …
  • Drake & Scull International PJSCの企業概要及び財務/SWOT分析
    Drake & Scull International PJSC Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Drake & Scull International PJSC annual and quarterly forecasts made by stock market experts. …
  • Shriram EPC Limited (SHRIRAMEPC):企業概要、財務及び戦略的SWOT分析
    Summary Shriram EPC Limited (Shriram EPC) is an engineering service company. The company provides design, engineering, procurement, construction and project management services. Its services include process and metallurgy, water infrastructure, power, and mining and mineral processing. Shriram EPC o …
  • Momina Krepost (5MR):企業の財務及び戦略的SWOT分析
    Summary Momina Krepost (Momina) is a medical equipment company that manufactures and sells single use medical devices. The company offers products such as syringes, injection needles for single use, sets, tubes, plastic throat pallet, catheter, urine collection bags, gynecological plastic pallet and …
  • Lifesensors, Inc.(製薬・医療分野):企業M&A動向
    Summary LifeSensors, Inc. (LifeSensors) is a biotechnology company. The company develops, manufactures and markets research tools for therapeutic, drug discovery, and research market. Its products include expression systems and ubiquitin research tools. The company provides services, such as custom …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆